\nMelanomul, cea mai grav\u0103 form\u0103 a cancerului de piele, este \u00eent\u00e2lnit \u00een 1% dintre cazuri, adesea \u00een r\u00e2ndul femeilor cu v\u00e2rste \u00eentre 20 \u015fi 39 de ani. Tot melanomul este responsabil de 5,000 de decese, din cei 18,000 de pacien\u0163i diagnostica\u0163i anual \u00een Europa (Melanoma Molecular Map Project \u2013 MMMP).<\/p>\n
\nAnul trecut, \u00een Rom\u00e2nia au fost diagnosticate peste 1,000 de cazuri de melanom ce au rezultat \u00een 364 de decese, conform Societ\u0103\u0163ii Rom\u00e2ne de Dermato \u2013 Oncologie.<\/p>\n
\nTot \u00een Rom\u00e2nia, rata de inciden\u0163\u0103 a melanomului este de 4,7 pentru b\u0103rba\u0163i \u015fi 4,4 pentru femei, pentru fiecare 100,000 de oameni. De\u015fi este u\u015for tratabil, lipsa de educa\u0163ie \u00een r\u00e2ndul rom\u00e2nilor, cu privire la importan\u0163a preven\u0163iei \u015fi a diagnostic\u0103rii \u00een stadiu incipient, a rezultat \u00een cea mai mic\u0103 \u015fans\u0103 de supravie\u0163uire din Europa – 5 ani.<\/p>\n
\nCancerul de piele poate fi tratat cu u\u015furin\u0163\u0103 dac\u0103 este descoperit \u00een stadiu incipient, \u00eenainte ca boala s\u0103 se extind\u0103, dar poate fi \u015fi prevenit, prin evitarea expunerii la soare \u015fi prin folosirea constant\u0103 a cremelor pentru protec\u0163ie solar\u0103.<\/p>\n
\nCu toate astea, potrivit publica\u0163iei britanice Express, 61% dintre b\u0103rba\u0163i nu sunt preocupa\u0163i de folosirea unei astfel de lo\u0163iuni atunci c\u00e2nd se expun razelor solare la orele de v\u00e2rf, comparativ cu 54% dintre femei care afirm\u0103 acela\u015fi lucru.<\/p>\n
\nNesacard este o solu\u0163ie pentru fina\u0163area investiga\u0163iilor medicale ini\u0163iale, pentru a ob\u0163ine suport \u00een navigarea medical\u0103 \u015fi second opinion \u00een cazul unui diagnostic de cancer de piele, \u015fi reprezint\u0103 o contribu\u0163ie caritabil\u0103 la progresul medical \u00een cercetarea \u015fi tratarea cancerului \u00een Europa.<\/p>\n
\n\u201eNesacard poate fi solicitat de oricine dore\u015fte s\u0103 contribuie la cercetarea oncologic\u0103 \u015fi s\u0103 aib\u0103 la \u00eendem\u00e2n\u0103 un suport financiar, \u00een caz de urgen\u0163\u0103, fie c\u0103 are sau nu suspiciuni de cancer. Pentru o contribu\u0163ie anual\u0103 de 33\u20ac clientul prime\u015fte un card cu un num\u0103r individual, cu ajutorul c\u0103ruia beneficiaz\u0103 de o finan\u0163are de 2.000 \u20ac cash, pentru a sus\u0163ine costurile ini\u0163iale de investiga\u0163ii \u015fi diagnostic\u201d, explic\u0103 Zahal Levy, Pre\u015fedinte MediHelp International.<\/p>\n
\nPrintre serviciile medicale ale c\u0103ror costuri pot fi acoperite de cardul NESA se reg\u0103sesc biopsia pielii, teste imagistice pentru diagnosticare, second opinion medical pentru confirmarea diagnosticului \u015fi navigare medical\u0103. <\/p>\n","protected":false},"excerpt":{"rendered":"
\u00cen contextul \u00een care inciden\u0163a cancerului de piele este \u00een continu\u0103 cre\u015ftere, cu peste 2 milioane de pacien\u0163i diagnostica\u0163i anual \u00een Europa, MediHelp International anun\u0163\u0103 c\u0103 Nesacard, cardul oncologic lansat \u00een Rom\u00e2nia \u00een luna iunie a acestui an, poate acoperi costurile diagnostic\u0103rii cancerului de piele, \u00een limita a 2,000 de euro. <\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[510],"tags":[14750,16199,14610,41769,7667,534,10565,7283,438,472,217,408,98],"class_list":["post-150431","post","type-post","status-publish","format-standard","hentry","category-actualitate","tag-acoperire","tag-anunt","tag-cancer","tag-cancer-de-piele","tag-card","tag-context","tag-contributie","tag-costuri","tag-europa","tag-finantare","tag-international","tag-pacienti","tag-romania"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/150431","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=150431"}],"version-history":[{"count":0,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/150431\/revisions"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=150431"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=150431"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=150431"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}